Hiroaki Goto

13PUBLICATIONS
141CO-AUTHORS
Molecular targetsCentral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical microbiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 26, 2026
A Three-Dimensional Culture-Drug Sensitivity Test Predicts MDM2 Inhibitor-Sensitivity in SMARCB1/INI1-Deficient Tumors.

|Dec 03, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle

|Aug 27, 2024
Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group.

Hiroaki Goto, Akiko Kada, Chitose Ogawa

|Jun 26, 2024
Acquired copy number amplification at the MYC enhancer in human B-precursor acute lymphoblastic leukemia cell lines.

Atsushi Watanabe, Lu Wang, Tze King Tan

|Dec 13, 2023
Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.

Akira Nishimura, Kazuaki Yokoyama, Takuya Naruto

|Sep 14, 2023
A short-term three dimensional culture-based drug sensitivity test is feasible for malignant bone tumors.

Hiroaki Goto, Takashi Ohtsu, Mieko Ito

Pageof 3

Frequent Collaborators

2 joint publications

Alexander Drilon

1 joint publications

Yoshinori Tsurusaki

1 joint publications

Wataru Nakamura

1 joint publications

Makoto Tahara